From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Harnblase Urothel.png
Transitional epithelium of the urinary bladder. Note the rounded surface of the apical cells -- a distinguishing characteristic of this type of epithelium.
Transverse section of ureter.
Anatomical terminology

Urothelium (or uroepithelium) is an example of transitional epithelium. It is the type of epithelium that lines much of the urinary tract including the renal pelvis, the ureters, the bladder,[1] and parts of the urethra.[2]

Structure and function[edit]

Urothelial tissue is highly specific to the urinary tract, and has high elasticity and trans-epithelial electrical resistance.[2]

Urothelium consists of approximately 3-5 cell layers, accompanied by a thick layer of protective glycoprotein plaques at its luminal (apical) surface, and is classified as transitional epithelium.[citation needed]


Epithelia are sites of specific diseases.[citation needed]

  • Cancers that originate in epithelial cells are termed carcinomas, and they are characterized as having lost the mature, differentiated morphology and molecular patterns of the normal tissue. Infectious diseases also afflict epithelia where diverse microbes (viruses, bacteria, fungi) have surface structures that bind specific features of particular epithelial cells (e.g., influenza virus binds respiratory epithelium). Genetic defects can also inhibit normal epithelial integrity, such as defects in intercellular adhesion molecules that result in blistering diseases.[citation needed]
  • The second most common infectious disease is urinary tract infection (UTI). UTIs afflict approximately half of all women during their lifetime, and about 25% of these women will suffer recurrent UTIs. The majority of these infections are due to uropathogenic Escherichia coli bacteria (commonly known as E. coli). However, UTIs can also develop in healthcare settings and such infections are caused by a greater frequency of non-E. coli bacteria.[citation needed]
  • One unusual condition which affects the urothelium is interstitial cystitis (IC), a condition with symptoms similar to UTI (urinary frequency, urinary urgency, pressure and/or pain). Urine culture, however, is negative. During hydrodistention of the bladder, small petechial hemorrhages (aka glomerulations) are frequently found throughout the bladder. Larger "Hunner's Ulcers", known for their characteristic waterfall bleeding effect, represent larger areas of bladder wall thinning and/or trauma. The cause of IC is currently unknown though some suggest that it could be genetic, the result of traumatic injury (aka chemical exposure), infection, autoimmune disease, etc. Researcher Susan Keay (University of Maryland) has found an unusual protein in the urine of IC patients which appears to interfere with healing, known as an Antiproliferative Factor. Research efforts into IC are focused on the urothelium, including newly discovered signaling molecules which suggest that the urothelium is far more than a barrier, as well as how the urothelium interacts with proximal nerves and smooth muscle.[citation needed]
  • Urothelium is susceptible to carcinoma. Because the bladder is in contact with urine for extended periods, chemicals that become concentrated in the urine can cause Bladder cancer. For example, cigarette smoking leads to the concentration of carcinogens in the urine and is a leading cause of bladder cancer. Aristolochic acid, a compound found in plants of the Aristolochiaceae family, also causes DNA mutations and is a cause of liver, urothelial and bladder cancers.[3] Occupational exposure to certain chemicals is also a risk factor for bladder cancer. This can include aromatic amines (aniline dye), polycytic aromatic hydrocarbons, and diesel engine exhaust.[4]

Urothelial lesions[edit]



  1. ^ Moro, C; Uchiyama, J; Chess-Williams, R (December 2011). "Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol". Urology. 78 (6): 1442.e9–15. doi:10.1016/j.urology.2011.08.039. PMID 22001099.
  2. ^ a b Andersson, 2011: p. 134
  3. ^ "Mutation signatures implicate aristolochic acid in bladder cancer development". Genome Medicine. 7 (1). Dec 2015. doi:10.1186/s13073-015-0161-3.
  4. ^ "Bladder cancer risk factors". Cancer Research UK. Retrieved 27 July 2014.


External links[edit]